April Salama, M.D.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma (NCT04971499) | April Salama, M.D. | 2022-09-06 |
Track April Salama, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.